PubMed Journals Articles About "Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor" RSS

14:21 EST 11th November 2019 | BioPortfolio

Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor articles that have been published worldwide.

More Information about "Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor" on BioPortfolio

We have published hundreds of Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor news stories on BioPortfolio along with dozens of Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor Clinical Trials and PubMed Articles about Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor Companies in our database. You can also find out about relevant Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor Drugs and Medications on this site too.

Showing "Melanoma Skin Cancer Tumor Characteristics Histologic Subtype Predictor" PubMed Articles 1–25 of 31,000+

Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.

To describe the behavior of non-melanoma skin cancer (NMSC) based on tumor's characteristics.

Identifying FL11 subtype by characterizing tumor immune microenvironment in prostate adenocarcinoma via Chou's 5-steps rule.

Prostate cancer is one of the leading causes of death in men worldwide, revealing a substantial heterogeneity in terms of molecular and clinical behaviors. Tumor infiltrating immune cell is associated with prognosis and response to immunotherapy in several cancer types. However, until now, the immune infiltrate profile of distinct subtypes for prostate cancer remains poorly characterized. In this study, using immune infiltration profiles as well as transcriptomic datasets, we characterized this subtype of p...

Current insights into the epigenetic mechanisms of skin cancer.

Skin cancer is a manifestation of tumors. The different types of skin cancer are named according to their source of tumor cells. Currently, there are three main types of skin cancer. They are squamous cell carcinoma (SCC), basal cell carcinoma (BCC) and melanoma. Their epidemiological characteristics, clinical classifications and treatment methods are somewhat different. The epigenetic modifications are also different in these three types of skin cancer. Epigenetics is the change in gene expression and func...

Melanoma screening using patient self-assessed risk and total body photography.

The current standard of care for high-risk melanoma patients is a two-step process using Total Body Photography (TBP) followed by dermoscopy and is limited to a select group of patients. Methods: A cross-sectional study of patient characteristics and self-reported melanoma risk factors associated with TBP usage and pathology-confirmed outcomes was conducted on a sample of 4,692 patients in a single practitioner private dermatology setting. Results: TBP patients were significantly more likely to be male, par...

Utility of core biopsy to identify histologic subtype and predict outcome for lung adenocarcinoma.

Lung adenocarcinoma histologic subtype is an important indicator of patient outcomes so pre-operative knowledge of subtype may be helpful to guide surgical planning. Our aim was to evaluate the sensitivity and prognostic efficacy of CT guided core needle biopsies to predict histologic subtype and patient outcome after surgery.

Biophysical and biochemical characteristics as complementary indicators of melanoma progression.

The multi-step character of cancer progression makes it difficult to define a unique biomarker of the disease. Interdisciplinary approaches, combining various complimentary techniques, especially those operating at a nanoscale level, potentially accelerate characterization of cancer cells or tissue properties. Here, we study a relation between the surface and biomechanical properties of melanoma cells, measured by mass spectrometry (ToF SIMS) and atomic force microscopy (AFM). In total, seven cell lines hav...

Knowledge, attitudes and behaviours in relation to skin cancer prevention.

The incidence of malignant melanoma is increasing faster than any other cancer, and it is now the second most common cancer in young adults. Most skin cancer prevention campaigns are based on the hypothesis that improved skin cancer knowledge leads to a change in sun-related behaviour.

Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer.

Incidence of non-melanoma skin cancers (NMSC) is increasing and can significantly impact on quality of life (QOL), yet there are few studies evaluating patient-reported outcome measures (PROM) in NMSC populations. We undertook a prospective feasibility study to evaluate a skin cancer-specific PROM, the Skin Cancer Quality of Life Impact Tool (SCQOLIT), in patients with a new diagnosis of NMSC.

Chemerin partly mediates tumor-inhibitory effect of all-trans retinoic acid via CMKLR1-dependent NK cells recruitment.

Down-regulated chemerin expression has been reported to correlate with poor prognosis of several types of cancer including melanoma. All-trans retinoic acid (atRA) is a potent inducer of chemerin and we previously reported that atRA inhibited murine melanoma growth via enhancement of anti-tumor T cell immunity. Here, we aimed to investigate whether loss of endogenous chemerin accelerated melanoma growth and chemerin was involved in the melanoma-inhibitory effect of atRA. We demonstrated that chemerin was co...

Prevalence and associated factors of skin cancer in aged nursing home residents: A multicenter prevalence study.

Non-melanoma-skin cancer is an emerging clinical problem in the elderly, fair skinned population which predominantly affects patients aged older than 70 years. Its steady increase in incidence rates and morbidity is paralleled by related medical costs. Despite the fact that many elderly patients are in need of care and are living in nursing homes, specific data on the prevalence of skin cancer in home care and the institutional long-term care setting is currently lacking. A representative multicenter preval...

Superficial radiotherapy for non-melanoma skin cancer of the lip: a 44-year Italian experience.

Radiotherapy is a valuable therapeutic option for the treatment of non-melanoma skin cancer (NMSC) in the ageing population, in non-surgical candidates, or when the tumour is extensive or localised in a cosmetically-sensitive area such as the lips.

Sasanquasaponin ΙΙΙ from Schima crenata Korth induces autophagy through Akt/mTOR/p70S6K pathway and promotes apoptosis in human melanoma A375 cells.

Melanoma is a high fatality skin cancer which lacks effective drugs. Sasanquasaponin, an important sort of constituents in theaceae, has been demonstrated to have potent anti-tumor effect in breast cancer and hepatocellular carcinoma. As a sasanquasaponin, we speculate that Sasanquasaponin III (SQS III) isolated from Schima crenata Korth may also have anti-tumor activity.

Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma.

Melanoma is the most fatal form of skin cancer. Current therapeutic approaches include surgical resection, chemotherapy, targeted therapy and immunotherapy. However, these treatment strategies are associated with development of drug resistance and severe side effects. In recent years, natural compounds have also been extensively studied for their anti-melanoma effects, including tumor growth inhibition, apoptosis induction, angiogenesis and metastasis suppression and cancer stem cell elimination. Moreover, ...

Application of parelectric spectroscopy to detect skin cancer-A pilot study.

The early detection of skin cancer is still challenging and calls for objective, fast diagnostic, and ideally non-invasive methods in order to leave the potentially malignant tumor cells unaltered. In this paper, the parelectric spectroscopy was applied to evaluate the potential of a non-invasive detection of basal cell carcinoma (BCC) and malignant melanoma.

PD-1 and PD-L1 inhibitors in the treatment of non-melanoma skin cancer: a systematic review.

Immunotherapy using PD-1 or PD-L1 inhibitors has been increasingly reported in a variety of non-melanoma skin cancers (NMSCs).

Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.

previous research on the risk of subsequent, primary non-cutaneous malignancies among patients with non-melanoma skin cancers (NMSCs) led to conflicting results. We aimed to investigate a possible link between NMSC and second primary malignancies by using the population-based data available in cancer registries.

Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia.

Epstein-Barr virus (EBV)-associated gastric cancer has been proposed to be a distinct gastric cancer molecular subtype. The prognostic significance of EBV infection in gastric cancer remains unclear and needs further investigation. Our study aimed to analyze EBV-positive and EBV-negative gastric cancer patients regarding their personal and tumor-related characteristics, and compare their overall survival.

Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy.

Melanoma has always been described as an immunogenic tumor. Despite that, until 2011 the standard of care in metastatic melanoma was chemotherapy, with low response rates and no clear impact on overall survival. Melanoma was the first cancer type to drive the use of immune-checkpoint inhibitors into clinical practice, which revolutionized the therapeutic paradigm not only in melanoma, but also in an increasing number of tumors. In this review, the preclinical bases and the main clinical studies that led to ...

Natural Melanoma-derived Extracellular Vesicles.

Melanoma cells produce a variety of extracellular vesicle (EV) types including shedding vesicles and exosomes (EXOs). These EVs are defined by their mechanism of cellular production. To date, the majority of EV investigations has centered around melanoma EXOs or small EVs (sEVs). Natural melanoma sEVs mediate pro-tumor processes including angiogenesis, immune regulation and modification of tissue microenvironments. A thorough examination of these processes reveals that they are interdependent. They work in ...

The genetic evolution of metastatic uveal melanoma.

Uveal melanoma is a clinically distinct and particularly lethal subtype of melanoma originating from melanocytes in the eye. Here, we performed multi-region DNA sequencing of primary uveal melanomas and their matched metastases from 35 patients. We observed previously unknown driver mutations and established the order in which these and known driver mutations undergo selection. Metastases had genomic alterations distinct from their primary tumors; metastatic dissemination sometimes occurred early during the...

British Association of Dermatologists (BAD) National Audit on Non-Melanoma Skin Cancer Excision 2016 in collaboration with the Royal College of Pathologists.

We conducted a re-audit of the surgical practice of United Kingdom (UK) dermatologists in the treatment of non-melanoma skin cancer and examined changes with reference to our previous audit in 2014. The audit was supplemented by a detailed assessment of completeness of the histopathology reports for each tumour.

Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice.

Expression patterns of estrogen receptors [ERα, ERβ, and G-protein associated ER (GPER)] in melanoma and skin may suggest their differential roles in carcinogenesis. Phytoestrogenic compound cyanidin-3-o-glucoside (C3G) has been shown to inhibit the growth and metastatic potential of melanoma, although the underlying molecular mechanism remains unclear. The aim of this study was to clarify the mechanism of action of C3G in melanoma and , as well as to characterize the functional expressions of ERs in mel...

Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma.

Tissue-resident memory T (T ) cells are abundant in the memory T cell pool and remain resident in peripheral tissues, such as the skin, where they act as alarm sensors or cytotoxic killers. T cells persist long after the pathogen is eliminated and can respond rapidly upon re-infection with the same antigen. When aberrantly activated, skin-located T cells have a profound role in various skin disorders, including vitiligo and melanoma. Autoreactive T cells are present in human lesional vitiligo skin and mouse...

Considerations for Timing of Defect Reconstruction in Cutaneous Melanoma of the Head and Neck.

The objective of this study is to identify the incidence and characteristics of cases with positive margins on wide local excision for cutaneous melanoma of the head and neck (CMHN) and therefore provide a potential basis for selectively delaying reconstruction pending final histological clearance of melanoma. A systematic review of English language articles was performed on studies retrieved from PubMed and Web of Science. Original investigations published between July 1999 and June 2018 reporting on margi...

Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer.

Diosmetin is a natural flavonoid obtained from citrus fruits and some medicinal herbs. Previous studies have reported the anti-cancer activity of diosmetin in some types of tumors. However, it is still unclear whether diosmetin exerts anti-cancer effects, particularly anti-angiogenic effects, in skin cancer. In this study, we used B16F10 melanoma cells and human umbilical vein endothelial cells to investigate the inhibitory effect of diosmetin on cell proliferation, migration and tube formation in vitro. Ra...

Quick Search